Tipranavir
Specifications
174484-41-4CAS Number
629-839-6EC Number
N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamideIUPAC Name
C31H33F3N2O5SChemical Formula
602.7 g/molMolecular Weight
Tipranavir; 174484-41-4; PNU-140690; U-140690; DTXSID6048622; CHEBI:63628; 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-; ZZT404XD09; 3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide; N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide; DTXCID9028548; 2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-; 2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-; tipranavirum; N-(3-((1R)-1-((2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide; RefChem:58436; tipranavir, (R-(R*,R*))-; J05AE09; 629-839-6; Aptivus; TPV; Tipranavir (INN); C31H33F3N2O5S; N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide; N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE; TIPRANAVIR [INN]; N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide; Aptivus(TM); N-(3-((R)-1-((R)-4-hydroxy-2-oxo-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide; Aptivus (TN); PNU 140690; Tipranavir [INN:BAN]; UNII-ZZT404XD09; Tipranavir?; HSDB 8083; NCGC00182028-01; U 140690; Tipranavir (Standard); Tipranavir Impurity 1; 1d4y; 2o4l; 2o4n; 2o4p; TIPRANAVIR [MI]; TIPRANAVIR [VANDF]; Epitope ID:231717; TIPRANAVIR [MART.]; TIPRANAVIR [WHO-DD]; SCHEMBL40629; SCHEMBL40630; N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide; TIPRANAVIR [EMA EPAR]; CHEMBL222559; orb1745235; Tipranavir - Bio-X trade mark; SCHEMBL29393318; SCHEMBL29714122; TIPRANAVIR [ORANGE BOOK]; GTPL12685; NZPXPXAGXYTROM-FYBSXPHGSA-N; SUJUHGSWHZTSEU-FYBSXPHGSA-N; EX-A4113; Tox21_112962; BDBM50479982; EBC-27374; HY-15148R; NSC831852; AKOS030254403; CS-1210; DB00932; FT28290; NSC-831852; NCGC00379087-01; NCGC00379087-02; AS-79082; BT300133; HY-15148; CAS-174484-41-4; NS00015496; T4578; D08605; F84910; EN300-19769351; Q423404; N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide; N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propy l-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamideSynonyms
